OnKure Therapeutics (OKUR) Research & Development (2020 - 2026)
OnKure Therapeutics (OKUR) recorded Research & Development of $12.61 million in Q2 2026, unchanged from $12.61 million a year earlier and up 7.7% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, OnKure Therapeutics' Research & Development came in at $46.95 million as of Jun 30, 2026, down 6.3% year-over-year; for FY2025, it was $48.26 million, up 10.2% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $43.8 million in FY2024 (+36.4%), $32.12 million in FY2023 (-14.8%), $37.71 million in FY2022 (+33.9%) and $28.17 million in FY2021 (+76.7%).
- Quarterly Research & Development has ranged from -$6.89 million in Q4 2023 to $14.4 million in Q2 2023 over the past five years.
- On a year-over-year basis, Research & Development rose in three of the last seven quarters, with growth averaging 3.7%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 110.3% in Q3 2021, against a decline of 25.7% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.71 million (Q1 2026), $10.72 million (Q4 2025) and $11.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | OnKure Therapeutics | 112.21 Mn | -385.72 Mn | - | 12.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.61 Mn |
| Mar 31, 2026 | 11.71 Mn |
| Dec 31, 2025 | 10.72 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Jun 30, 2025 | 12.61 Mn |
| Mar 31, 2025 | 13.01 Mn |
| Dec 31, 2024 | 14.36 Mn |
| Sep 30, 2024 | 10.12 Mn |
| Jun 30, 2024 | 10.75 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | -6.89 Mn |
| Sep 30, 2023 | 13.62 Mn |
| Jun 30, 2023 | 14.40 Mn |
| Mar 31, 2023 | 10.99 Mn |
| Dec 31, 2022 | 10.36 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 8.13 Mn |
| Mar 31, 2022 | 9.28 Mn |
| Dec 31, 2021 | 7.10 Mn |
| Sep 30, 2021 | 9.32 Mn |
API Access
OnKure Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();